Abstract
Since streptozotocin (STZ) exhibits beta-cell toxicity, mediated through diverse mechanisms, multiple toxin resistance can be expected in insulin-secretory cells rendered STZ-resistant. RINm5F, but not all cell lines surviving STZ treatment, possess higher insulin content than native parental cells and additional tolerance against alloxan. To understand the impact of STZ tolerant cell selection on toxin resistance and insulin-secretory function, STZ-resistant BRIN-BD11 cells were generated by iterative acute exposure to 20 mM STZ. These cells, denoted BRINst cells, exhibited resistance to toxic challenges from STZ, H2O2, and ninhydrin. Insulin content and both glucose and arginine-stimulated insulin secretion were significantly enhanced in BRINst cells. The toxin-resistance of BRINst cells was gradually lost during continuous cultivation without STZ challenge. However, enhanced insulin secretory capacity at high passage in BRINst cells persisted. Although total SOD activity was decreased, catalase activity was increased and appeared to be important for the ninhydrin and STZ resistance of BRINst cells. This was associated with reductions of both STZ- and ninhydrin-induced DNA damage, although DNA repair was abolished. Further characterization of cells exhibiting multiple toxin tolerance and an enhanced insulin secretory function could provide useful lessons for understanding of beta-cell survival.
Similar content being viewed by others
References
J.W. Baynes, in: Drugs, Diet, and Disease, ed by P.R. Flatt, C. Ioannides, (Ellis Horwood Limited, 1995)
P.R. Flatt, O. Shibier, C. Ioannides, S.K. Swanston Flatt, Exp. Clin. Endocrinol. 93, 193–202 (1989)
C.C. Rerup, Pharmacol. Rev. 22, 485–518 (1970)
P. Bouchard, P. Sai, G. Reach, I. Caubarrere, D. Ganeval, R. Assan, Diabetes 31, 40–45 (1982)
T. Helgason, M.R. Jonasson, Lancet 2, 716–720 (1981)
J.H. Karam, P.A. Lewitt, C.W. Young, R.E. Nowlain, B.J. Frankel, H. Fujiya, Z.R. Freedman, G.M. Grodsky, Diabetes 29, 971–978 (1980)
C.J. Bailey, P.R. Flatt, in: Textbook of Diabetes, ed. by J.C. Pickup, G. Williams (Blackwell Science, Osney Mead, 2003)
F. Lally, A.J. Bone, in Textbook of Diabetes, ed. by J.C. Pickup, G. Williams (Blackwell Science, Osney Mead, 2003)
M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, S. Lenzen, Diabetologia 43, 1528–1533 (2000)
W.J. Schnedl, S. Ferber, J.H. Johnson, C.B. Newgard, Diabetes 43, 1326–1333 (1994)
B.E. Tuch, S. Beynon, M.T. Tabiin, R. Sassoon, R.J. Goodman, A.M. Simpson, J Autoimmun. 10, 239–244 (1997)
C. Park, J.R. Kim, J.K. Shim, B.S. Kang, Y.G. Park, K.S. Nam, Y.C. Lee, C.H. Kim, Arch. Biochem. Biophys. 362, 217–224 (1999)
K. Asayama, D. English, A.E. Slonim, I.M. Burr, Diabetes 33, 160–163 (1984)
K.S. Saini, C. Thompson, C.M. Winterford, N.I. Walker, D.P. Cameron, Biochem. Mol. Biol. Int. 39, 1229–1236 (1996)
N. Takasu, I. Komiya, T. Asawa, Y. Nagasawa, T. Yamada, Diabetes 40, 1141–1145 (1991)
J. Turk, J.A. Corbett, S. Ramanadham, A. Bohrer, M.L. McDaniel, Biochem. Biophys. Res. Commun. 197, 1458–1464 (1993)
D.M. Kokkinakis, M.A. von Wronski, T.H. Vuong, T.P. Brent, S.C. Schold Jr., Br. J. Cancer 75, 779–788 (1997)
M. Murata, A. Takahashi, I. Saito, S. Kawanishi, Biochem. Pharmacol. 57, 881–887 (1999)
N.A. Berger, Radiat. Res. 101, 4–15 (1985)
H. Okamoto, Biomed. Biochim. Acta. 44, 15–20 (1985)
A. Bast, G. Wolf, R. Oberbaumer, R. Walther, Diabetologia 45, 867–876 (2002)
H. Chen, E.C. Carlson, L. Pellet, J.T. Moritz, P.N. Epstein, Diabetes 50, 2040–2046 (2001)
K.D. Kroncke, K. Fehsel, A. Sommer, M.L. Rodriguez, V. Kolb-Bachofen, Biol. Chem. Hoppe. Seyler. 376, 179–185 (1995)
K. Bloch, P. Vardi, Int. J. Exp. Diabetes Res. 1, 233–237 (2001)
K.O. Bloch, M. Vorobeychik, K. Yavrians, P. Vardi, Biochem. Pharmacol. 65, 1797–1805 (2003)
K.O. Bloch, R. Zemel, O.V. Bloch, H. Grief, P. Vardi, Int. J. Exp. Diabetes Res. 1, 211–219 (2000)
G. Chen, H.E. Hohmeier, R. Gasa, V.V. Tran, C.B. Newgard, Diabetes 49, 562–570 (2000)
G. Chen, H.E. Hohmeier, C.B. Newgard, J. Biol. Chem. 276, 766–772 (2001)
K. Bloch, P. Vardi, Diabetes Metab. Res. Rev. 21, 253–261 (2005)
Y. Abdel-Wahab, H.-K. Liu, N.H. McClenaghan, P.R. Flatt, Diabetic Med. 23, 33–34 (2006)
N.H. McClenaghan, C.R. Barnett, E. Ah-Sing, Y.H. Abdel-Wahab, F.P. O’Harte, T.W. Yoon, S.K. Swanston-Flatt, P.R. Flatt, Diabetes 45, 1132–1140 (1996)
N.H. McClenaghan, C.R. Barnett, F.P. O’Harte, P.R. Flatt, J Endocrinol. 151, 349–357 (1996)
V.J. McKelvey-Martin, M.H. Green, P. Schmezer, B.L. Pool-Zobel, M.P. De Meo, A. Collins, Mutat. Res. 288, 47–63 (1993)
P.R. Flatt, C.J. Bailey, Diabetologia 20, 573–577 (1981)
K. Grankvist, J. Sehlin, I.B. Taljedal, Acta Pharmacol. Toxicol. (Copenh.) 58, 175–181 (1986)
H. Kaneto, J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, N. Taniguchi, Diabetes 44, 733–738 (1995)
E. Strandell, S. Sandler, J. Endocrinol. 153, 81–86 (1997)
S.P. LeDoux, S.E. Woodley, N.J. Patton, G.L. Wilson, Diabetes 35, 866–872 (1986)
Z. Ling, M. Van de Casteele, D.L. Eizirik, D.G. Pipeleers, Diabetes 49, 340–345 (2000)
I. Flechner, K. Maruta, V. Burkart, K. Kawai, H. Kolb, U. Kiesel, Diabetes Res. 13, 67–73 (1990)
N.S. Kwon, S.H. Lee, C.S. Choi, T. Kho, H.S. Lee, Faseb J. 8, 529–533 (1994)
P.R. Flatt, S.K. Swanston Flatt, K.S. Tan, V. Marks, Gen. Pharmacol. 18, 293–297 (1987)
S. Lortz, M. Tiedge, T. Nachtwey, A.E. Karlsen, J. Nerup, S. Lenzen, Diabetes 49, 1123–1130 (2000)
M. Tiedge, H. Steffeck, M. Elsner, S. Lenzen, Diabetes 48, 514–523 (1999)
N. Takasu, T. Asawa, I. Komiya, Y. Nagasawa, T. Yamada, J. Biol. Chem. 266, 2112–2114 (1991)
T. Ishii, H. Iwahashi, R. Sugata, R. Kido, J. Biochem. (Tokyo) 104, 610–615 (1988)
M. Poje, B. Rocic, M. Sikirica, I. Vickovic, M. Bruvo, J. Med. Chem. 26, 861–864 (1983)
C.A. Delaney, D.L. Eizirik, Braz. J. Med. Biol. Res. 29, 569–579 (1996)
Y. Uchigata, H. Yamamoto, A. Kawamura, H. Okamoto, J. Biol. Chem. 257, 6084–6088 (1982)
Acknowlegments
This work was mainly supported by University Research Strategy Funding and Vice Chancellor’s research studentship award to H-K Liu and partially supported by a research grant from NRICM (NRICM94-DHM-6).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, HK., McCluskey, J.T., McClenghan, N.H. et al. Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity. Endocr 32, 20–29 (2007). https://doi.org/10.1007/s12020-007-9000-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-007-9000-7